Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Reduced oxydised N-acetyl heparin

EU orphan designation number: EU/3/15/1487   
Active ingredient: Reduced oxydised N-acetyl heparin
Indication: Treatment of plasma cell myeloma
Sponsor: Leadiant GmbH
Liebherrstraße 22, Altstadt-Lehel, 80538 München, Bavaria, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
26/05/2015 Orphan designation EMA/OD/277/14 (2015)3567 of 21/05/2015
29/06/2015 Transfer of orphan designation EMA/OD/277/14/T/01 (2015)4504 of 25/06/2015
12/01/2017 Change of name and/or address of sponsor
8/03/2019 Transfer of orphan designation EMA/OD/0000004452 (2019)1951 of 6/03/2019